You have 9 free searches left this month | for more free features.

methylprednisolone and cyclophosphamide

Showing 1 - 25 of 2,306

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Membranous Nephropathy Trial in Beijing (Prednisone, MP and CTX)

Terminated
  • Idiopathic Membranous Nephropathy
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Feb 2, 2022

ANCA Associated Vasculitis Trial in Netherlands (Rituximab, endoxan, Methylprednisolone)

Recruiting
  • ANCA Associated Vasculitis
  • Leiden, Zuid-Holland, Netherlands
  • +3 more
May 16, 2022

Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)

Not yet recruiting
  • Lymphoma
  • Lymphoma, Large B-Cell, Diffuse
  • Boston, Massachusetts
  • +1 more
Apr 4, 2023

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Telitacicept
  • +6 more
  • (no location specified)
Dec 28, 2022

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Thrombocytopenia Trial in China (Hydroxychloroquine, Cyclophosphamide, Azathioprine)

Terminated
  • Thrombocytopenia
  • Bangbu, Anhui, China
  • +14 more
Feb 26, 2022

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial (Cyclophosphamide, Vincristine, Dexamethasone)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • (no location specified)
Aug 2, 2022

Fanconi Anemia Trial in Minneapolis (biological, drug, procedure)

Completed
  • Fanconi Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 8, 2021

Systemic Lupus Erythematosus (SLE) Trial in São Paulo (Cyclophosphamide, Methylprednisolone, Prednisone)

Terminated
  • Systemic Lupus Erythematosus (SLE)
  • São Paulo, Sao Paulo, Brazil
  • +1 more
Jul 14, 2021

Fanconi Anemia Trial in Minneapolis (anti-thymocyte globulin, filgrastim, busulfan)

Completed
  • Fanconi Anemia
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 4, 2021

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Recruiting
  • Myasthenia Gravis
  • Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)
  • Beijing, Beijing, China
    Xuan Wu Hospital, Capital Medical University
Aug 19, 2021

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult

Completed
  • Contiguous Stage II Adult Lymphoblastic Lymphoma
  • +5 more
  • Sacramento, California
    University of California Davis
Mar 8, 2022

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

Advanced Follicular Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine, Cyclophosphamide)

Active, not recruiting
  • Advanced Follicular Lymphoma
  • Boulder, Colorado
  • +33 more
Nov 21, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Chicago (Cyclophosphamide, Mesna, rATG)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Chicago, Illinois
    Northwestern University
Jan 6, 2021

Lymphoma Trial in Lyon (asparaginase, cyclophosphamide, cytarabine)

Completed
  • Lymphoma
  • Lyon, France
    Centre Leon Berard
Feb 19, 2021

Leukemia Trial in Germany (Amsacrine, Clofarabine, Cyclophosphamide)

Active, not recruiting
  • Leukemia
  • Bielefeld, Germany
  • +13 more
May 16, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

Lupus Nephritis Trial in United States (Rituximab, Cyclophosphamide, Prednisone)

Completed
  • Lupus Nephritis
  • Rituximab
  • +6 more
  • Birmingham, Alabama
  • +14 more
Nov 13, 2020

Lupus Erythematosus, Systemic Trial run by the NCI (drug, biological, other, procedure)

Completed
  • Lupus Erythematosus, Systemic
  • fludarabine phosphate
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 9, 2020

Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)

Terminated
  • Stiff-Person Syndrome
  • Autologous Hematopoietic Stem Cells
  • +6 more
  • Chicago, Illinois
    Northwestern University
Jan 6, 2021

Scleroderma, Systemic Trial in Chicago (Peripheral Blood Stem Cells, Cyclophosphamide, Mesna)

Terminated
  • Scleroderma, Systemic
  • Peripheral Blood Stem Cells
  • +6 more
  • Chicago, Illinois
    Northwestern University
Jul 7, 2020